LIXONDEL Trademark

Trademark Overview


On Friday, September 18, 2015, a trademark application was filed for LIXONDEL with the United States Patent and Trademark Office. The USPTO has given the LIXONDEL trademark a serial number of 79175038. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, May 12, 2024. This trademark is owned by Novartis AG. The LIXONDEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
lixondel

General Information


Serial Number79175038
Word MarkLIXONDEL
Filing DateFriday, September 18, 2015
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, May 12, 2024
Registration Number4906846
Registration DateTuesday, March 1, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateFriday, September 6, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, October 30, 2015LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, November 2, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 6, 2015APPLICATION FILING RECEIPT MAILED
Monday, November 9, 2015ASSIGNED TO EXAMINER
Tuesday, November 10, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 29, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, November 25, 2015NOTICE OF PUBLICATION
Tuesday, December 15, 2015PUBLISHED FOR OPPOSITION
Tuesday, March 1, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, September 19, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, March 31, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Thursday, March 31, 2016FINAL DISPOSITION PROCESSED
Thursday, March 31, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 4, 2016NOTIFICATION PROCESSED BY IB
Thursday, September 19, 2019DEATH OF INTERNATIONAL REGISTRATION
Monday, June 3, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, May 29, 2020NOTIFICATION PROCESSED BY IB